At Adamas Biotech, we develop clinically validated, nutraceutical-based prophylactic and therapeutic solutions for a range of clinical and wellness indications. We are committed to evidence-based medicine and to the scientific methods integral to creating innovative solutions in the nutraceuticals field.

Through our unique scientific-nutraceuticals approach, we utilize raw materials with clinically validated biological activities. Our initial focus has been on exploiting the antioxidant, anti-angiogenic and anti-inflammatory properties of green tea extracts (GTEs) for the treatment of high-grade intraepithelial neoplasia (HG-PIN) and for blocking its progression into prostate cancer. The efficacy of our proprietary formulations has been demonstrated in a placebo-controlled, randomized, double-blind phase II study with two-year follow up.  Our platform expands vertically to include solutions for wound care, psoriasis, alopecia and sports medicine.

Due to lack of regulatory requirements, the majority of supplements and nutraceuticals in the market do not offer standardized and guaranteed concentrations of the actual bioactive compounds, and are not clinically validated for efficacy. Adamas Biotech’s production processes and formulations are significantly different from current market offerings: we develop scientifically validated products that are markedly superior in terms of efficacy, absorption, metabolism and product storability, and allied data that may lead to approval of health claims from the EFSA.

At Adamas Biotech, our mission is to improve health and wellbeing through the use of clinically proven, nature-based sustainable solutions.